DFDA

Watchful Waiting / Cardiovascular Risk Factor Modification

Treatment for Non Rheumatic Calcific Aortic Valve Disease

Effectiveness
10%
Safety Score
95%
Clinical Trials
100
Participants
40K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Time to Effect
Long-term (for risk factor benefits), immediate (for watchful waiting assessment)
Treatment Duration
Lifetime (for monitoring and lifestyle)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$0
Total Annual:$500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0
Watchful Waiting / Cardiovascular Risk Factor Modification Outcomes

for Non Rheumatic Calcific Aortic Valve Disease

Efficacy Outcomes
Overall Effectiveness
+10%
Common Side Effects
No direct side effects, but progression of AS may occur
+100%

Sources:

researchgate.net
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov